Q

uniQure NV
D

QURE

16.190
USD
0.39
(2.47%)
مغلق
حجم التداول
60,854
الربح لكل سهم
-3
العائد الربحي
-
P/E
-4
حجم السوق
888,295,597
أصول ذات صلة
C
CLLS
-0.03000
(-1.04%)
2.85000 USD
C
CRSP
0.853
(1.45%)
59.683 USD
E
EDIT
0.08000
(2.70%)
3.04000 USD
F
FATE
0.00000
(0.00%)
1.08000 USD
N
NTLA
0.090
(0.83%)
10.995 USD
R
RCKT
0.01500
(0.50%)
3.04500 USD
S
SGMO
0.02420
(4.37%)
0.57800 USD
V
VYGR
0.01000
(0.27%)
3.74000 USD
المزيد
الأخبار المقالات

العنوان: uniQure NV

القطاع: Healthcare
الصناعة: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.